Comera Life Sciences Q2 EPS $(0.08) Up From $(1.14) YoY, Sales $315.06K Up From $146.73K YoY
Comera Life Sciences Q2 EPS $(0.08) Up From $(1.14) YoY, Sales $315.06K Up From $146.73K YoY
Comera Life Sciences第二季度每股收益爲0.08美元，高於同比（1.14美元），銷售額爲315.06萬美元，高於同比的14.673萬美元
Comera Life Sciences (NASDAQ:CMRA) reported quarterly losses of $(0.08) per share. This is a 92.98 percent increase over losses of $(1.14) per share from the same period last year. The company reported $315.06 thousand in sales this quarter. This is a 114.72 percent increase over sales of $146.73 thousand the same period last year.
Comera Life Sciences（納斯達克股票代碼：CMRA）公佈季度每股虧損0.08美元。這比去年同期的每股虧損（1.14美元）增加了92.98％。該公司報告本季度銷售額爲315.06萬美元。這比去年同期的14.673萬美元的銷售額增長了114.72％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。